{"id":"W2120639027","doi":"10.1016/s1470-2045(12)70525-9","title":"Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":223,"is_retracted":false,"has_abstract":false,"ca_institutions":"Translational Research in Oncology; Hôpital du Saint-Sacrement; Essar Steel Algoma (Canada); Dr. H. Bliss Murphy Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Docetaxel; Hazard ratio; Anthracycline; Cyclophosphamide; Clinical endpoint; Taxane; Cancer; Chemotherapy; Oncology; Surgery; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004151202,0.001692188,0.002873711,0.0003373252,0.0005138345,0.001384275,0.00100169,0.001903729,0.005127554],"category_scores_gemma":[0.003188108,0.0006064337,0.002570148,0.0006906195,0.0009328448,0.001338914,0.0005827103,0.004066231,0.001059408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001803898,"about_ca_system_score_gemma":0.001694864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003676947,"about_ca_topic_score_gemma":0.008714193,"domain_scores_codex":[0.9985159,0.0008935784,0.00005652293,0.0001775137,0.0001112732,0.0002451879],"domain_scores_gemma":[0.9978191,0.0006634406,0.0005559849,0.000252327,0.0001057798,0.0006034192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9665903,0.002773359,0.002313869,0.0004195782,0.001922422,0.00003562128,0.00007647027,0.001120432,0.001436035,0.0001311385,0.00247066,0.02071018],"study_design_scores_gemma":[0.8674954,0.09460334,0.02738482,0.0001719465,0.004001463,0.0001491573,0.0001091111,0.0008500508,0.000760705,0.0007502238,0.003670455,0.00005339592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804253,0.009745165,0.000403459,0.001401516,0.0003759266,0.0008572576,0.003421043,0.00006838304,0.003301921],"genre_scores_gemma":[0.9806451,0.004775587,0.0006426718,0.001629957,0.0003035561,0.001212448,0.005968078,0.00005273324,0.004769881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005127554,"threshold_uncertainty_score":0.02195388,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01830545395135363,"score_gpt":0.3107389978638279,"score_spread":0.2924335439124743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}